tradingkey.logo
tradingkey.logo
Search

Hong Kong Crypto Stocks Rally Across the Board — Leading Biotech Surges Nearly 9%

TradingKey
AuthorBlock Tao
Jul 28, 2025 5:45 AM
facebooktwitterlinkedin
View all comments0

TradingKey – With just three days left until Hong Kong’s Stablecoin Ordinance takes effect, crypto-stocks on the HKEX surged sharply on Monday, July 28.

Despite the Hang Seng Index rising and then pulling back intraday, crypto concept stocks posted strong gains:

  • Leading Biotech (HK.00399) jumped 8.77%, nearing its July 2 peak
  • YF Finance (HK.00376) spiked over 9% in early trading, later settling at +5.68%
  • Guotai Junan International (HK.01788) rose nearly 5%
  • ZhongAn Online (HK.06060) gained over 3%
  • Golden Surge Investment (HK.01328) climbed more than 2%
  • Yika (HK.09923), OSL Group (HK.00863), and Delin Holdings (HK.01709) also joined the rally

The surge reflects growing investor optimism ahead of August 1, when Hong Kong’s Stablecoin Ordinance officially goes live, ushering in a new licensing regime for stablecoin issuers and service providers. This countdown is expected to further boost crypto-linked equities, as Hong Kong positions itself as a regional Web3 and digital asset hub.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.